Found: 14
Select item for more details and to access through your institution.
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tofacitinib Monotherapy in Rheumatoid Arthritis: Clinical Trials and Real-World Data Contextualization of Patients, Efficacy, and Treatment Retention.
- Published in:
- Open Access Rheumatology: Research & Reviews, 2024, v. 16, p. 115, doi. 10.2147/OARRR.S446431
- By:
- Publication type:
- Article
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 7, p. 2127, doi. 10.1007/s10067-020-04956-1
- By:
- Publication type:
- Article
383 Integrated safety analysis of abrocitinib in 635 adolescent patients with moderate-to-severe atopic dermatitis with over 1000 patient-years of exposure.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.011
- By:
- Publication type:
- Article
330 Safety of abrocitinib in 3582 patients with moderate-to-severe atopic dermatitis with over 900 patients exposed for almost 2 years.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii20, doi. 10.1093/bjd/ljac140.025
- By:
- Publication type:
- Article
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 1, p. 283, doi. 10.1007/s40744-018-0097-3
- By:
- Publication type:
- Article
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 1, p. 203, doi. 10.1007/s40744-018-0093-7
- By:
- Publication type:
- Article
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study.
- Published in:
- Rheumatology, 2019, v. 58, n. 1, p. 70, doi. 10.1093/rheumatology/key250
- By:
- Publication type:
- Article
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 4, p. 639, doi. 10.1007/s40257-024-00869-w
- By:
- Publication type:
- Article
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1442, doi. 10.1111/apt.16626
- By:
- Publication type:
- Article
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis—two cases in real world clinical practice. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1209, doi. 10.1111/apt.15735
- By:
- Publication type:
- Article
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 10, p. 1068, doi. 10.1111/apt.15514
- By:
- Publication type:
- Article
Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 10, p. 1960, doi. 10.1002/art.40189
- By:
- Publication type:
- Article
Using ultrasound radiomics to forecast adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
- Published in:
- Echocardiography, 2024, v. 41, n. 8, p. 1, doi. 10.1111/echo.15907
- By:
- Publication type:
- Article